Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2006-04-04
2006-04-04
O'Sullivan, Peter (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S019300, C564S094000
Reexamination Certificate
active
07022738
ABSTRACT:
The present invention provides a compound represented by the formula (I):wherein R1, R2and R3each represents a lower alkyl group.
REFERENCES:
patent: 6057290 (2000-05-01), Fukiage et al.
patent: 6423691 (2002-07-01), Azuma et al.
patent: 0 641 563 (1995-03-01), None
patent: 6-29229 (1994-04-01), None
patent: 96/16079 (1996-05-01), None
Crawford et al., “The Design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B”, Biochem. J., vol. 253, pp. 751-758, (1988).
Angliker et al., “Inactivation of Calpain by Peptyidyl Fluoromethyl Ketones”, J. Med. Chem., vol. 35, No. 2, pp. 216-220, (1992).
Azuma et al., “Cysteine protease inhibitor E64 reduces the rate of formation of selenite cataract in the whole animal”, Current Eye Research, vol. 10, No. 7, pp. 657-666, (1991).
Wang et al., “Calpain inhibition: an overview of its therapeutic potential”, Trends in Pharmaceutical Sciences (TIPS), vol. 15, pp. 412-419, (1994).
Inoue Jun
Nakamura Masayuki
O'Sullivan Peter
Senju Pharmaceutical Co. Ltd.
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
α-ketoamide derivative and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with α-ketoamide derivative and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and α-ketoamide derivative and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3546653